Lilly’s Zyprexa Transitioning Off Florida Medicaid Preferred Drug List
This article was originally published in The Pink Sheet Daily
Executive Summary
Patients will have 60 days to seek alternative treatment, after which time Lilly’s Zyprexa and Symbyax will require prior authorization. The antipsychotic drugs are being dropped from the preferred drug list after Lilly and Florida could not come to an agreement over supplemental rebates.
You may also be interested in...
House Medicaid Reform Limits Antipsychotic/Antidepressant Prior Authorization
House Energy & Commerce Committee Chairman Barton opposed the amendment, which was included in the committee’s budget reconciliation legislation.
House Medicaid Reform Limits Antipsychotic/Antidepressant Prior Authorization
House Energy & Commerce Committee Chairman Barton opposed the amendment, which was included in the committee’s budget reconciliation legislation.
Zyprexa Marketing Documents Sought By Florida Medicaid Fraud Unit
State Attorney General’s investigation could extend to other Lilly products, the company says in an SEC filing.